US Patent Issued to NOVABIOTICS on March 17 for "Dosage regime" (British Inventor)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,050, issued on March 17, was assigned to NOVABIOTICS Ltd. (Aberdeenshire, Great Britain).

"Dosage regime" was invented by Deborah O'Neil (Aberdeenshire, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to use of cysteamine, formulations comprising cysteamine and pharmaceutically acceptable salts of cysteamine in the treatment of cystic fibrosis and conditions associated with cystic fibrosis."

The patent was filed on Oct. 17, 2019, under Application No. 17/286,282.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF...